Track POMDOCTOR LIMITED American Depositary Shares — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

POMDOCTOR LIMITED American Depositary Shares POM · Stock Open POMDOCTOR LIMITED American Depositary Shares in new tab

0.7700 USD
EPS
-10.04
P/B
-0.10
Loading chart...
Key Metrics
EPS-10.04
Book Value-8.77
Price to Book-0.10
Growth
Revenue Growth0.06%

DCF valuation

Model fair value for POMDOCTOR LIMITED American Depositary Shares (POM)
Result
Sign in to run the valuation for POM.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

POMDOCTOR LIMITED American Depositary Shares Logo POMDOCTOR LIMITED American Depositary Shares Analysis (POM)

USA Official Website Stock

Is POMDOCTOR LIMITED American Depositary Shares a good investment? POMDOCTOR LIMITED American Depositary Shares (POM) is currently trading at 0.7700 USD.

Investor FAQ

Does POMDOCTOR LIMITED American Depositary Shares pay a dividend?

No, it does not currently pay a dividend.

What asset class is POMDOCTOR LIMITED American Depositary Shares?

POMDOCTOR LIMITED American Depositary Shares is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

Exchange Ticker
US POM
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
June 22, 2026 1:18
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion